key: cord-0960847-zn6fx3gz
authors: Assan, Florence; Sbidian, Emilie; Bachelez, Hervé
title: Response to “New-onset pustular psoriasis in the setting of severe acute respiratory syndrome coronavirus 2 infection causing coronavirus disease 2019”
date: 2021-03-04
journal: JAAD Case Rep
DOI: 10.1016/j.jdcr.2021.02.024
sha: 847614e35a165e0b3cd6907857cbf0f31e6d8328
doc_id: 960847
cord_uid: zn6fx3gz

nan

We read with interest the recent report of a new-onset of pustular psoriasis in the setting of severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infection by Matthieu et al. (1) . Before the SARS-COV-2 pandemic context, a spectrum of respiratory viruses (RV) has been identified for the first time by our group as triggering factors of different psoriasis endotypes flares, including three generalized pustular psoriasis (GPP), two of which carryied homozygous IL36RN mutations. (2) . In our study, several RNA viruses, mainly Rhinovirus 

New-onset pustular psoriasis in the setting of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causing Coronavirus Disease 2019 (COVID-19). JAAD Case Rep

Respiratory virus infection triggers acute psoriasis flares across different clinical subtypes and genetic backgrounds

Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis

Promotes Systemic IFN-I Responses in Severe Forms of Psoriasis

Regulation and Function of the IL-1 Family Cytokine IL-1F9 in Human Bronchial Epithelial Cells

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Inhibition of the Interleukin-36 Pathway for the Treatment of Generalized Pustular Psoriasis